Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00956410
Show Display Options
Download search resultsDownload the search results for:
NCT00956410 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
Condition: Alzheimer Disease
Intervention: Biological: CAD106

Indicates status has not been verified in more than two years